多模式镇痛与肩关节置换术后结局:基于人群的研究
住院患者中多模式镇痛(>2种方式)与术后第1天阿片类药物用量(OME)减少19.4%相关,但门诊患者中OME增加13.7%。多模式镇痛仅与住院患者阿片类药物用量减少相关,未改善其他结局。
要点
- 住院肩关节置换患者中,多模式镇痛(>2种方式)与术后第1天OME减少19.4%相关。
- 门诊肩关节置换患者中,多模式镇痛与OME增加13.7%相关。
- 联合神经阻滞会减弱多模式镇痛对阿片类药物用量的影响。
核心结论
- 多模式镇痛与住院肩关节置换患者阿片类药物用量减少相关,但未改善其他结局。
- 门诊肩关节置换患者中多模式镇痛与阿片类药物用量增加相关。
研究设计与样本
- 回顾性队列研究,使用Premier Healthcare Database数据。
- 纳入2010至2019年接受住院或门诊肩关节置换术(反式、全肩、部分)的患者。
- 比较单纯阿片类镇痛与多模式镇痛(1种、2种或>2种额外镇痛方式,伴或不伴神经阻滞)。
- 采用多变量回归模型分析多模式镇痛与阿片类药物用量(OME)、费用、住院时间及阿片相关不良事件(以纳洛酮使用近似)的关联。
主要发现
- 住院患者中,多模式镇痛(>2种方式)不伴神经阻滞 vs 单纯阿片类镇痛:术后第1天OME adjusted减少19.4%(95%CI -21.2%至-17.6%),未调整中位OME从45mg降至30mg。
- 住院患者整个住院期间OME adjusted减少6.0%(95%CI -7.2%至-4.9%),未调整中位OME从173mg降至135mg。
- 门诊患者中,多模式镇痛(>2种方式)不伴神经阻滞 vs 单纯阿片类镇痛:OME adjusted增加13.7%(95%CI +4.4%至+23.0%),未调整中位OME从110mg增至131mg。
- 在住院和门诊中,多模式镇痛基础上加用神经阻滞均减弱了对阿片类药物用量的影响。
临床怎么用
- 住院肩关节置换术患者可考虑使用多模式镇痛(>2种方式)以减少术后阿片类药物用量。
- 门诊肩关节置换术患者使用多模式镇痛需谨慎评估,因其与阿片类药物用量增加相关。
- 联合神经阻滞可能减弱多模式镇痛减少阿片类药物用量的效果。
局限性
- 回顾性研究设计,可能存在残余混杂。
- 阿片相关不良事件以纳洛酮使用近似,可能低估实际发生率。
- 仅报告了OME和部分结局,未涉及其他临床结局的详细数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Multimodal analgesia has been associated with reduced opioid utilization, opioid-related complications, and improved recovery in various orthopedic surgeries; however, large sample size data is lacking for shoulder surgery. METHODS: A retrospective review using the Premier Healthcare Database of patients who underwent inpatient or outpatient (reverse, total, partial) shoulder arthroplasty from 2010 to 2019. Opioid-only analgesia was compared with multimodal analgesia, categorized into 1, 2, or >2 additional analgesic modes, with/without a nerve block. Multivariable regression models measured associations between multimodal analgesia and opioid charges (in oral morphine equivalents (OME)), cost and length of stay, and opioid-related adverse effects (approximated by naloxone use). We report % change and 95% CIs. RESULTS: Among 176 225 procedures, 169 679 (75.7% multimodal analgesia use) and 6546 (37.8% multimodal analgesia use) were inpatient and outpatient shoulder arthroplasties, respectively. Among inpatients, multimodal analgesia (>2 modes) without a nerve block (vs opioid-only analgesia) was associated with adjusted reductions in OMEs on postoperative day 1: -19.4% (95% CI -21.2% to -17.6%/representing unadjusted median OME reductions from 45 to 30 mg). For total hospitalization, this was -6.0% (95% CI -7.2% to -4.9%/representing unadjusted median OME reductions from 173 to 135 mg). Conversely, for outpatients, this was +13.7% change in OMEs (95% CI +4.4% to +23.0%/representing unadjusted median OME increases from 110 to 131 mg). In both settings, addition of a nerve block to multimodal analgesia attenuated effects in terms of opioid charges. CONCLUSIONS: Multimodal analgesia is associated with reductions in opioid charges-specifically inpatient setting-but not various other outcomes.
引用
- Liu H, Zhong H, Zubizarreta N, et al. Multimodal pain management and postoperative outcomes in inpatient and outpatient shoulder arthroplasties: a population-based study. Reg Anesth Pain Med. 2025. PMID: 38499359. doi:10.1136/rapm-2023-104984
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。